Celebrities, sports legends, corporate leaders and more joined NFL Hall of Famer Nick Buoniconti, his son Marc and Event Chair Mark Dalton as they hosted a sold-out crowd in celebration of the 30th Annual Great Sports Legends Dinner to benefit The Buoniconti Fund to Cure Paralysis.
Held at New York’s famed Waldorf Astoria on October 6, the dinner paid tribute to philanthropic heroes and sports icons who inspire and motivate those affected by spinal cord injuries, and raised more than $12 million for research and the Human Clinical Trials Initiative at The Miami Project to Cure Paralysis at the University of Miami Miller School of Medicine.
Dean Pascal J. Goldschmidt sent this message on Thursday: It is with great sadness that I let you know that our dear friend, colleague and mentor Eckhard Podack passed away today at the Mayo Clinic in Rochester after an extraordinary fight for his life.
A new grant from the National Institutes of Health (NIH) will support innovative clinical trials involving drug treatment by the Florida Node Alliance, based at the Miller School of Medicine. Over the past 15 years, the University team has received more than $73 million in funding from NIH’s National Institute on Drug Abuse, including a new five-year grant, which will provide more than $3 million in the coming year.
Dipen J. Parekh, M.D., a member of Sylvester Comprehensive Cancer Center and Professor and Chairman of the Department of Urology and Director of Robotic Surgery at the University of Miami Miller School of Medicine, was in London on Sunday, October 4, where he received the BJU International – Vattikuti Foundation Robotics Prize. The award was given to honor a paper he and colleagues published in 2014.
A delegation of Italian scientists and biomedical engineering specialists visited the University of Miami Miller School of Medicine on October 1 to explore potential multi-disciplinary collaborations in nanotechnology, tissue engineering and regenerative medicine.
Sylvester Comprehensive Cancer Center recently welcomed a new member to its team of cancer experts. Riccardo Lencioni, M.D., joined Sylvester as Director of Interventional Oncology Research from the University of Pisa in Italy, where he was a professor at the School of Medicine. Lencioni is an accomplished interventional oncology specialist, particularly well-known for his influential work on liver cancer.